Form 4: Winston J. Churchill Reports Acquisition of Dividend Equivalent Units in Amkor Technology

Sentiment:

SEC Form 4 Filing


Director Winston J. Churchill reports the acquisition of dividend equivalent units related to restricted stock units in Amkor Technology.

Summary

  • Winston J. Churchill, a director of Amkor Technology, Inc. (AMKR), filed a Form 4 on September 25, 2024, reporting a transaction.
  • On September 23, 2024, Churchill acquired 14,864 dividend equivalent units (DEUs) related to previously granted restricted stock units (RSUs).
  • These DEUs were accrued upon the payment of a dividend and are subject to the same provisions as the RSUs granted on May 14, 2024.
  • Following the reported transaction, Churchill beneficially owns 5,882.2486 shares of common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports a routine transaction of dividend equivalent units.

Positives

  • The acquisition of dividend equivalent units suggests continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it involves the acquisition of dividend equivalent units by a director.

Key Dates

DateDescription
05/14/2024Date the Reporting Person was granted time-vested restricted stock units (RSUs) of Amkor Technology, Inc.
09/23/2024Date of the transaction: acquisition of dividend equivalent units (DEUs).
09/25/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.